 | • レポートコード：B-GIR08C4278 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、膵臓癌・胆管癌治療薬の世界市場について調べ、まとめました。種類別セグメントは、血管内皮細胞増殖因子受容体、プログラム細胞死タンパク質1、シグナルトランスデューサー活性化因子3、その他等、用途別セグメントは、等に区分しました。膵臓癌・胆管癌治療薬の世界市場概観、企業動向、企業別膵臓癌・胆管癌治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・膵臓癌・胆管癌治療薬の市場概観 ・膵臓癌・胆管癌治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・膵臓癌・胆管癌治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・膵臓癌・胆管癌治療薬の世界市場規模 ・膵臓癌・胆管癌治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・膵臓癌・胆管癌治療薬のアメリカ市場規模推移 ・膵臓癌・胆管癌治療薬のカナダ市場規模推移 ・膵臓癌・胆管癌治療薬のメキシコ市場規模推移 ・膵臓癌・胆管癌治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・膵臓癌・胆管癌治療薬のドイツ市場規模推移 ・膵臓癌・胆管癌治療薬のイギリス市場規模推移 ・膵臓癌・胆管癌治療薬のロシア市場規模推移 ・膵臓癌・胆管癌治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・膵臓癌・胆管癌治療薬の日本市場規模推移 ・膵臓癌・胆管癌治療薬の中国市場規模推移 ・膵臓癌・胆管癌治療薬の韓国市場規模推移 ・膵臓癌・胆管癌治療薬のインド市場規模推移 ・膵臓癌・胆管癌治療薬の東南アジア市場規模推移 ・膵臓癌・胆管癌治療薬の南米市場分析（ブラジル、アルゼンチン等） ・膵臓癌・胆管癌治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・膵臓癌・胆管癌治療薬の種類別分析/販売量、売上、市場シェア（血管内皮細胞増殖因子受容体、プログラム細胞死タンパク質1、シグナルトランスデューサー活性化因子3、その他） ・膵臓癌・胆管癌治療薬の用途別分析/市場規模（） ・膵臓癌・胆管癌治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・膵臓癌・胆管癌治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
It is a drug for treating pancreatic cancer with bile duct cancer.
Scope of the Report:
Pancreatic cancer is a disease in which malignant (cancer) cells are found in pancreatic tissue. The pancreas is a large gland located in the abdominal cavity and is responsible for the secretion of digestive juice and insulin.
Symptoms and signs include upper abdominal pain, yellowish skin and white eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Susceptibility factors include age, gender, smoking, diabetes, and family history. Treatment includes surgery, chemotherapy and radiation therapy.
Cholangiocarcinoma or cholangiocarcinoma is a tumor that occurs in the bile duct. A series of tubes in the bile duct are essential for bile secretion, and bile plays an important role in digestion. Symptoms include abdominal discomfort, loss of appetite, fever and weight loss. Treatment includes chemotherapy and radiation therapy.
The global Pancreatic and Bile Duct Cancer Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pancreatic and Bile Duct Cancer Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Pancreatic and Bile Duct Cancer Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pancreatic and Bile Duct Cancer Drug market by product type and applications/end industries.
Market Segment by Companies, this report covers
3-V Biosciences Inc
4P-Pharma SAS
4SC AG
AB Science SA
AbbVie Inc
AbGenomics International Inc
Ability Pharmaceuticals SL
Aclaris Therapeutics Inc
Actuate Therapeutics Inc
Aduro BioTech Inc
Advantagene Inc
AGV Discovery SAS
AIMM Therapeutics BV
Alissa Pharma
Alligator Bioscience AB
Allinky Biopharma
Altor BioScience Corp
amcure GmbH
Amgen Inc
Amplia Therapeutics Pty Ltd
Anavex Life Sciences Corp
Andarix Pharmaceuticals Inc
ANP Technologies Inc
AntiCancer Inc
APEIRON Biologics AG
Apexigen Inc
Aphios Corp
Aposense Ltd
ARMO Biosciences Inc
ArQule Inc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Vascular Endothelial Growth Factor Receptors
Programmed Cell Death Protein 1
Signal Transducer Activator of Transcription 3
Others
Market Segment by Applications, can be divided into
Pancreatic Cancer
Cholangiocarcinoma
Table of Contents
1 Pancreatic and Bile Duct Cancer Drug Market Overview
1.1 Product Overview and Scope of Pancreatic and Bile Duct Cancer Drug
1.2 Classification of Pancreatic and Bile Duct Cancer Drug by Types
1.2.1 Global Pancreatic and Bile Duct Cancer Drug Revenue Comparison by Types (2019-2024)
1.2.2 Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Types in 2018
1.2.3 Vascular Endothelial Growth Factor Receptors
1.2.4 Programmed Cell Death Protein 1
1.2.5 Signal Transducer Activator of Transcription 3
1.2.6 Others
1.3 Global Pancreatic and Bile Duct Cancer Drug Market by Application
1.3.1 Global Pancreatic and Bile Duct Cancer Drug Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Pancreatic Cancer
1.3.3 Cholangiocarcinoma
1.4 Global Pancreatic and Bile Duct Cancer Drug Market by Regions
1.4.1 Global Pancreatic and Bile Duct Cancer Drug Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Pancreatic and Bile Duct Cancer Drug Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Pancreatic and Bile Duct Cancer Drug Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pancreatic and Bile Duct Cancer Drug Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Pancreatic and Bile Duct Cancer Drug Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pancreatic and Bile Duct Cancer Drug Status and Prospect (2014-2024)
1.5 Global Market Size of Pancreatic and Bile Duct Cancer Drug (2014-2024)
2 Company Profiles
2.1 3-V Biosciences Inc
2.1.1 Business Overview
2.1.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 3-V Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.2 4P-Pharma SAS
2.2.1 Business Overview
2.2.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 4P-Pharma SAS Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.3 4SC AG
2.3.1 Business Overview
2.3.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 4SC AG Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.4 AB Science SA
2.4.1 Business Overview
2.4.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AB Science SA Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.5 AbbVie Inc
2.5.1 Business Overview
2.5.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AbbVie Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.6 AbGenomics International Inc
2.6.1 Business Overview
2.6.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AbGenomics International Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.7 Ability Pharmaceuticals SL
2.7.1 Business Overview
2.7.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ability Pharmaceuticals SL Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.8 Aclaris Therapeutics Inc
2.8.1 Business Overview
2.8.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Aclaris Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.9 Actuate Therapeutics Inc
2.9.1 Business Overview
2.9.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Actuate Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.10 Aduro BioTech Inc
2.10.1 Business Overview
2.10.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Aduro BioTech Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.11 Advantagene Inc
2.11.1 Business Overview
2.11.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Advantagene Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.12 AGV Discovery SAS
2.12.1 Business Overview
2.12.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 AGV Discovery SAS Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.13 AIMM Therapeutics BV
2.13.1 Business Overview
2.13.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 AIMM Therapeutics BV Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.14 Alissa Pharma
2.14.1 Business Overview
2.14.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Alissa Pharma Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.15 Alligator Bioscience AB
2.15.1 Business Overview
2.15.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Alligator Bioscience AB Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.16 Allinky Biopharma
2.16.1 Business Overview
2.16.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Allinky Biopharma Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.17 Altor BioScience Corp
2.17.1 Business Overview
2.17.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Altor BioScience Corp Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.18 amcure GmbH
2.18.1 Business Overview
2.18.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 amcure GmbH Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.19 Amgen Inc
2.19.1 Business Overview
2.19.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Amgen Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.20 Amplia Therapeutics Pty Ltd
2.20.1 Business Overview
2.20.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Amplia Therapeutics Pty Ltd Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.21 Anavex Life Sciences Corp
2.21.1 Business Overview
2.21.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Anavex Life Sciences Corp Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.22 Andarix Pharmaceuticals Inc
2.22.1 Business Overview
2.22.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Andarix Pharmaceuticals Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.23 ANP Technologies Inc
2.23.1 Business Overview
2.23.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 ANP Technologies Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.24 AntiCancer Inc
2.24.1 Business Overview
2.24.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 AntiCancer Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.25 APEIRON Biologics AG
2.25.1 Business Overview
2.25.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 APEIRON Biologics AG Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.26 Apexigen Inc
2.26.1 Business Overview
2.26.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Apexigen Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.27 Aphios Corp
2.27.1 Business Overview
2.27.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Aphios Corp Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.28 Aposense Ltd
2.28.1 Business Overview
2.28.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Aposense Ltd Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.29 ARMO Biosciences Inc
2.29.1 Business Overview
2.29.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 ARMO Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
2.30 ArQule Inc
2.30.1 Business Overview
2.30.2 Pancreatic and Bile Duct Cancer Drug Type and Applications
2.30.2.1 Product A
2.30.2.2 Product B
2.30.3 ArQule Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pancreatic and Bile Duct Cancer Drug Market Competition, by Players
3.1 Global Pancreatic and Bile Duct Cancer Drug Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Pancreatic and Bile Duct Cancer Drug Players Market Share
3.2.2 Top 10 Pancreatic and Bile Duct Cancer Drug Players Market Share
3.3 Market Competition Trend
4 Global Pancreatic and Bile Duct Cancer Drug Market Size by Regions
4.1 Global Pancreatic and Bile Duct Cancer Drug Revenue and Market Share by Regions
4.2 North America Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
4.3 Europe Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
4.5 South America Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
5 North America Pancreatic and Bile Duct Cancer Drug Revenue by Countries
5.1 North America Pancreatic and Bile Duct Cancer Drug Revenue by Countries (2014-2019)
5.2 USA Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
5.3 Canada Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
5.4 Mexico Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
6 Europe Pancreatic and Bile Duct Cancer Drug Revenue by Countries
6.1 Europe Pancreatic and Bile Duct Cancer Drug Revenue by Countries (2014-2019)
6.2 Germany Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
6.3 UK Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
6.4 France Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
6.5 Russia Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
6.6 Italy Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue by Countries
7.1 Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue by Countries (2014-2019)
7.2 China Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
7.3 Japan Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
7.4 Korea Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
7.5 India Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
8 South America Pancreatic and Bile Duct Cancer Drug Revenue by Countries
8.1 South America Pancreatic and Bile Duct Cancer Drug Revenue by Countries (2014-2019)
8.2 Brazil Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
8.3 Argentina Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
8.4 Colombia Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Pancreatic and Bile Duct Cancer Drug by Countries
9.1 Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue by Countries (2014-2019)
9.2 Saudi Arabia Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
9.3 UAE Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
9.4 Egypt Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
9.5 Nigeria Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
9.6 South Africa Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
10 Global Pancreatic and Bile Duct Cancer Drug Market Segment by Type
10.1 Global Pancreatic and Bile Duct Cancer Drug Revenue and Market Share by Type (2014-2019)
10.2 Global Pancreatic and Bile Duct Cancer Drug Market Forecast by Type (2019-2024)
10.3 Vascular Endothelial Growth Factor Receptors Revenue Growth Rate (2014-2024)
10.4 Programmed Cell Death Protein 1 Revenue Growth Rate (2014-2024)
10.5 Signal Transducer Activator of Transcription 3 Revenue Growth Rate (2014-2024)
10.6 Others Revenue Growth Rate (2014-2024)
11 Global Pancreatic and Bile Duct Cancer Drug Market Segment by Application
11.1 Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Application (2014-2019)
11.2 Pancreatic and Bile Duct Cancer Drug Market Forecast by Application (2019-2024)
11.3 Pancreatic Cancer Revenue Growth (2014-2019)
11.4 Cholangiocarcinoma Revenue Growth (2014-2019)
12 Global Pancreatic and Bile Duct Cancer Drug Market Size Forecast (2019-2024)
12.1 Global Pancreatic and Bile Duct Cancer Drug Market Size Forecast (2019-2024)
12.2 Global Pancreatic and Bile Duct Cancer Drug Market Forecast by Regions (2019-2024)
12.3 North America Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
12.4 Europe Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
12.6 South America Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Pancreatic and Bile Duct Cancer Drug Picture
Table Product Specifications of Pancreatic and Bile Duct Cancer Drug
Table Global Pancreatic and Bile Duct Cancer Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Types in 2018
Figure Vascular Endothelial Growth Factor Receptors Picture
Figure Programmed Cell Death Protein 1 Picture
Figure Signal Transducer Activator of Transcription 3 Picture
Figure Others Picture
Table Global Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) by Application (2014-2024)
Figure Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Applications in 2018
Figure Pancreatic Cancer Picture
Figure Cholangiocarcinoma Picture
Table Global Market Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) and Growth Rate (2014-2024)
Table 3-V Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 3-V Biosciences Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table 3-V Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table 4P-Pharma SAS Basic Information, Manufacturing Base and Competitors
Table 4P-Pharma SAS Pancreatic and Bile Duct Cancer Drug Type and Applications
Table 4P-Pharma SAS Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table 4SC AG Basic Information, Manufacturing Base and Competitors
Table 4SC AG Pancreatic and Bile Duct Cancer Drug Type and Applications
Table 4SC AG Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table AB Science SA Basic Information, Manufacturing Base and Competitors
Table AB Science SA Pancreatic and Bile Duct Cancer Drug Type and Applications
Table AB Science SA Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table AbbVie Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table AbbVie Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table AbGenomics International Inc Basic Information, Manufacturing Base and Competitors
Table AbGenomics International Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table AbGenomics International Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Ability Pharmaceuticals SL Basic Information, Manufacturing Base and Competitors
Table Ability Pharmaceuticals SL Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Ability Pharmaceuticals SL Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Aclaris Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Aclaris Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Aclaris Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Actuate Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Actuate Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Actuate Therapeutics Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Aduro BioTech Inc Basic Information, Manufacturing Base and Competitors
Table Aduro BioTech Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Aduro BioTech Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Advantagene Inc Basic Information, Manufacturing Base and Competitors
Table Advantagene Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Advantagene Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table AGV Discovery SAS Basic Information, Manufacturing Base and Competitors
Table AGV Discovery SAS Pancreatic and Bile Duct Cancer Drug Type and Applications
Table AGV Discovery SAS Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table AIMM Therapeutics BV Basic Information, Manufacturing Base and Competitors
Table AIMM Therapeutics BV Pancreatic and Bile Duct Cancer Drug Type and Applications
Table AIMM Therapeutics BV Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Alissa Pharma Basic Information, Manufacturing Base and Competitors
Table Alissa Pharma Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Alissa Pharma Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Alligator Bioscience AB Basic Information, Manufacturing Base and Competitors
Table Alligator Bioscience AB Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Alligator Bioscience AB Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Allinky Biopharma Basic Information, Manufacturing Base and Competitors
Table Allinky Biopharma Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Allinky Biopharma Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Altor BioScience Corp Basic Information, Manufacturing Base and Competitors
Table Altor BioScience Corp Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Altor BioScience Corp Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table amcure GmbH Basic Information, Manufacturing Base and Competitors
Table amcure GmbH Pancreatic and Bile Duct Cancer Drug Type and Applications
Table amcure GmbH Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Inc Basic Information, Manufacturing Base and Competitors
Table Amgen Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Amgen Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Amplia Therapeutics Pty Ltd Basic Information, Manufacturing Base and Competitors
Table Amplia Therapeutics Pty Ltd Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Amplia Therapeutics Pty Ltd Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Anavex Life Sciences Corp Basic Information, Manufacturing Base and Competitors
Table Anavex Life Sciences Corp Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Anavex Life Sciences Corp Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Andarix Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table Andarix Pharmaceuticals Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Andarix Pharmaceuticals Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table ANP Technologies Inc Basic Information, Manufacturing Base and Competitors
Table ANP Technologies Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table ANP Technologies Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table AntiCancer Inc Basic Information, Manufacturing Base and Competitors
Table AntiCancer Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table AntiCancer Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table APEIRON Biologics AG Basic Information, Manufacturing Base and Competitors
Table APEIRON Biologics AG Pancreatic and Bile Duct Cancer Drug Type and Applications
Table APEIRON Biologics AG Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Apexigen Inc Basic Information, Manufacturing Base and Competitors
Table Apexigen Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Apexigen Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Aphios Corp Basic Information, Manufacturing Base and Competitors
Table Aphios Corp Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Aphios Corp Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Aposense Ltd Basic Information, Manufacturing Base and Competitors
Table Aposense Ltd Pancreatic and Bile Duct Cancer Drug Type and Applications
Table Aposense Ltd Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table ARMO Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table ARMO Biosciences Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table ARMO Biosciences Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table ArQule Inc Basic Information, Manufacturing Base and Competitors
Table ArQule Inc Pancreatic and Bile Duct Cancer Drug Type and Applications
Table ArQule Inc Pancreatic and Bile Duct Cancer Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) by Players (2014-2019)
Table Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Players (2014-2019)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Players in 2017
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Players in 2018
Figure Global Top 5 Players Pancreatic and Bile Duct Cancer Drug Revenue Market Share in 2018
Figure Global Top 10 Players Pancreatic and Bile Duct Cancer Drug Revenue Market Share in 2018
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Regions (2014-2019)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Regions (2014-2019)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Regions in 2018
Figure North America Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Europe Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure South America Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Table North America Pancreatic and Bile Duct Cancer Drug Revenue by Countries (2014-2019)
Table North America Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries (2014-2019)
Figure North America Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries (2014-2019)
Figure North America Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries in 2018
Figure USA Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Canada Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Mexico Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Table Europe Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) by Countries (2014-2019)
Figure Europe Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries in 2018
Figure Germany Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure UK Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure France Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Russia Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Italy Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries in 2018
Figure China Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Japan Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Korea Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure India Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Table South America Pancreatic and Bile Duct Cancer Drug Revenue by Countries (2014-2019)
Table South America Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries (2014-2019)
Figure South America Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries (2014-2019)
Figure South America Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries in 2018
Figure Brazil Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Argentina Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Colombia Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure UAE Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Egypt Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure Nigeria Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Figure South Africa Pancreatic and Bile Duct Cancer Drug Revenue and Growth Rate (2014-2019)
Table Global Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) by Type (2014-2019)
Table Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Type (2014-2019)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Type (2014-2019)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Type in 2018
Table Global Pancreatic and Bile Duct Cancer Drug Revenue Forecast by Type (2019-2024)
Figure Global Pancreatic and Bile Duct Cancer Drug Market Share Forecast by Type (2019-2024)
Figure Global Vascular Endothelial Growth Factor Receptors Revenue Growth Rate (2014-2019)
Figure Global Programmed Cell Death Protein 1 Revenue Growth Rate (2014-2019)
Figure Global Signal Transducer Activator of Transcription 3 Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Pancreatic and Bile Duct Cancer Drug Revenue by Application (2014-2019)
Table Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Application (2014-2019)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Application (2014-2019)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Share by Application in 2018
Table Global Pancreatic and Bile Duct Cancer Drug Revenue Forecast by Application (2019-2024)
Figure Global Pancreatic and Bile Duct Cancer Drug Market Share Forecast by Application (2019-2024)
Figure Global Pancreatic Cancer Revenue Growth Rate (2014-2019)
Figure Global Cholangiocarcinoma Revenue Growth Rate (2014-2019)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Pancreatic and Bile Duct Cancer Drug Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Pancreatic and Bile Duct Cancer Drug Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
Figure Europe Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
Figure South America Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Pancreatic and Bile Duct Cancer Drug Revenue Market Forecast (2019-2024)
世界の膵がん治療市場：市場規模・現状・予測 Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …- 世界の膵がんの診断市場：市場規模・現状・予測 Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Bio…
- 癌免疫療法創薬アウトソーシングの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Cancer Immunotherapy Drug Discovery Outsourcing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years…
- 甲状腺がん薬市場：世界及び中国の市場分析・予測（～2024年） Thyroid Cancer Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Thyroid Cancer Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Thyroid Cancer Drug manufactur…
- 小分子癌治療薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Small Molecule Cancer Drug is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Small Molecule Cancer …